-
Published 7/29/2026
Hamparsumian A, La J, Dharne M, Gilbert G, Brophy MT, Do NV, Kim DH, Driver JA, Fillmore NR, DuMontier C. Association of Frailty With Transfusions, Hospitalizations, and Survival in Patients With Myelodysplastic Syndrome Initiating Hypomethylating Agents. EJHaem. 2026 Aug; 7(4):e70352. PMID: 42529661.
-
Published 7/21/2026
Lazzaro A, Nannini K, Yildirim C, Huhmann L, Culnan JM, Corrigan JK, Elbers D, Do NV, Brophy MT, Munshi NC, Fillmore NR, Edwards CV. Evolution of Real-World Front-Line Treatment Patterns in Multiple Myeloma. Blood Adv. 2026 Jul 21. PMID: 42480210.
-
Published 7/16/2026
La J, Wang L, Corrigan JK, Lang D, Do NV, Brophy MT, Fillmore NR, Paller CJ. Abiraterone or Enzalutamide for Patients With Metastatic Castration-Sensitive Prostate Cancer: A Nationwide Veterans Affairs Study. JCO Clin Cancer Inform. 2026; 10(3):e2500213. PMID: 42462188.
-
Published 7/14/2026
La J, Jafari O, Nannini K, Do NV, Brophy MT, Fillmore NR, Li A. Temporal validation of the electronic health record cancer-associated thrombosis model in patients with low bleeding risk. Res Pract Thromb Haemost. 2026 Jul; 10(5):106830. PMID: 42568708.
-
Published 6/1/2026
Liebers DT, He T, Betensky RA, Zheng C, Swinnerton KN, Jacobson S, Huhmann L, Brophy MT, Do NV, Gilsanz P, Osorio RS, Pomara N, Convit A, Goff DC, Iosifescu DV, Fillmore NR, Ramos-Cejudo J. Sodium-Glucose Cotransporter 2 Inhibitors and Dementia Risk in Patients With Psychiatric Disorders. JAMA Netw Open. 2026 Jun 01; 9(6):e2619985. PMID: 42377960.